ClinicalTrials.gg
RecruitingNCT07401095Updated Feb 12, 2026

BioBrace® in Arthroscopic Brostrom Lateral Ankle Ligament Repair

An interventional study of Brostrom repair with augmentation and Brostrom repair without augmentation in ATFL, Lateral Ankle Instability and Anterior Talofibular Ligament, sponsored by Hancock Orthopedics. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-12.

Sponsored by Hancock Orthopedics · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Dec 2025; still recruiting 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 83 studies in Ankle Injuries with a site in United States — 16 open to participants now, 18 under way, none of them phase 3. Ankle Injuries · United States.

Planned enrollment
43rd of 71
40 · median 50
Started
2025
with 8 others
No phase
54 of 83
14 open now
Primary completion
2028-06
later than 14 of 17 live
Registered
81st of 83
by date

Among the 83 studies in Ankle Injuries with a site in United States, this one is the 43rd largest by planned enrollment of the 71 interventional ones that give a count, is one of 9 that started in 2025, is one of 54 with no phase, reaches primary completion later than 14 of the 17 other live ones, and was the 81st registered.

Ankle Injuries

354 studies on the registry are indexed under Ankle Injuries; 77 are open to participants now.

Browse Ankle Injuries studies →

Open to participants now

16 of the 83 studies in Ankle Injuries with a site in United States are open now. Recruiting first, the newest first:

10 more — sign in →

All 16 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 47 Ankle Injuries studies recruiting now, 11 (23%) set no upper age limit and 33 (70%) stop at 75 or younger; 10 take children under 18; 8 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 83 studies in Ankle Injuries with a site in United States, or all of them as a file.
02

Study summary

The purpose of this investigation is to evaluate pre- and post-operative patient reported outcomes and functional scores after an all-arthroscopic Brostrom repair using either a suture anchor construct alone or suture anchors with the BioBrace Implant.

Read the detailed description

This is a single-center, prospective, randomized (1:1) interventional study investigating the use of the BioBrace® Implant in lateral ankle ligament repair procedures performed using an all-arthroscopic Broström technique. Eligible participants who meet study criteria will be enrolled and randomized into one of two study arms:

Control Group: Arthroscopic Broström repair using a suture-anchor construct only.

Treatment Group: Arthroscopic Broström repair using a suture-anchor construct augmented with the BioBrace® Implant.

Clinical evaluations will be conducted at baseline (preoperatively), and postoperatively at 1, 3, and 6 weeks, as well as at 3, 6, and 12 months using various patient-reported outcome measures to asses pain, function, activity and safety post surgery.

03

Conditions studied

  • ATFL
  • Lateral Ankle Instability
  • Anterior Talofibular Ligament
  • Anterior Talofibular Ligament Injury
  • Brostrom Procedure
  • Brostrom
  • Ankle

Browse trials for

Keywords

  • BioBrace
  • The BioBrace Implant
  • BioBrace Implant
  • ATFL
  • Lateral Ankle Instability
  • CONMED
  • Ankle
  • Ankle Injury
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. At least 18 years of age at the time of surgery.
  2. Able to read, understand and sign the form.
  3. Willing to be available to attend each protocol required visit and complete the study required questionnaires.
  4. Scheduled to undergo primary, arthroscopic Brostrom repair.

Exclusion criteria

Exclusion Criteria:

  1. Previous Brostrom surgery.
  2. Concomitant procedures that would change the post operative course/recovery (i.e. total ankle replacement, OCD repair, foot/ankle osteotomies) as determined by the Investigator.
  3. Currently participating or plans to enroll in another clinical trial during this study that would affect the outcomes of this study as determined by the Investigator.
  4. History of non-compliance with medical treatment or clinical trial participation.
  5. The subject is physically or mentally compromised (e.g., currently being treated for a psychiatric disorder, senile dementia, Alzheimer's disease, etc.), to the extent that the Investigator judges the subject to be unable or unlikely to remain compliant with protocol required follow-up.
  6. Females of who are either pregnant or breastfeeding or plan to become pregnant during the course of the study.
  7. Any comorbidity or condition that renders the patient a poor surgical candidate as determined by the Investigator.
  8. to any device materials including collagen of animal origin (bovine type-I), poly-L-lactic acid (PLLA) or polyethylene glycol (PEG)
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Childbearing potential

Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).

Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Sham comparator
    Control - Repair Only Group

    Procedure: Standard of care Brostrom repair.

    Other: Brostrom repair without augmentation

  • Experimental
    BioBrace Augment Group

    Brostrom repair with BioBrace

    Device: Brostrom repair with augmentation

Interventions

  • DeviceBrostrom repair with augmentation

    Brostrom repair with BioBrace

  • OtherBrostrom repair without augmentation

    Brostrom repair without BioBrace

06

What researchers measure

Primary outcomes

  1. American Orthopedic Foot and Ankle Society score (AOFAS)

    The AOFAS Score is a clinician-based assessment tool that evaluates pain, function, and alignment in patients with foot and ankle disorders. It provides a composite score ranging from 0 to 100, with higher scores indicating better function. The system includes region-specific scales (e.g., ankle-hindfoot, midfoot, hallux) and combines both patient-reported symptoms and objective clinician findings

    Time frame: Baseline, 1, 3, and 6 weeks & 3, 6, and 12 months

  2. Foot Function Index (FFI)

    The Foot Function Index (FFI) is a patient-reported questionnaire used to assess how foot conditions affect pain, disability, and activity limitation. It includes 23 items rated on a 0-10 scale, with higher scores indicating greater impairment in foot function.

    Time frame: Baseline, 1, 3, and 6 weeks & 3, 6, and 12 months

  3. Visual Analog Scale (VAS)

    The Visual Analog Scale (VAS) is a tool used to measure the intensity of pain or other subjective symptoms. It consists of a 10-cm line labeled "no pain" at one end and "worst imaginable pain" at the other; patients mark their pain level on the line, which is then measured to provide a numerical score from 0 to 100.

    Time frame: Baseline, 1, 3, and 6 weeks & 3, 6, and 12 months

  4. Karlsson-Peterson score

    The Karlsson-Peterson Score is a functional ankle assessment tool that evaluates symptoms such as pain, swelling, instability, stiffness, stair-climbing ability, running ability, work/activity level, and need for support, producing a total score up to 100, with higher scores indicating better ankle function.

    Time frame: Baseline, 1, 3, and 6 weeks & 3, 6, and 12 months

07

Study locations

1 of 1 sites recruiting
  • Hancock Orthopedics
    Greenfield, Indiana 46140, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2025 (actual). Primary completion is estimated for Jun 2028, 30 months after the start.

Of 141 non-industry interventional studies with no phase under Ankle Injuries, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 31. This study's planned 30 months is above that.

Counting every sponsor, half of 144 studies reached it within 9 months; a quarter within 4 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 3, 2026
First posted
Feb 10, 2026
StartActual
Dec 8, 2025
Primary completionEst.
Jun 2028
CompletionEst.
Dec 2028
Last update
Feb 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07401095
Lead sponsor
Hancock Orthopedics
Collaborators
CONMED Corporation
Responsible party
Sponsor
First posted
Feb 10, 2026
Start date
Dec 8, 2025
Primary completion
Jun 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Feb 12, 2026

Study contacts

Jay Badell, DPM, MS, FACFAS
Contact
JBadell@hancockhealth.org
317-477-6683

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion